CLINICAL INTERPRETATION GUIDE (ANOMALOUS MERGING, 3 DAYS)

1. Overall Performance:
- Best balanced accuracy: 0.76 (ConvTran)
- Best F1 score: 0.75 (ROCKET)

2. Breakthrough Findings:
- Perfect non-viable detection: All models (BA=1.0)
- Anomalous group: ConvTran (BA=0.84, F1=0.75) leads
- 3PN reliability: ROCKET (F1=0.84) > ConvTran (F1=0.71)

3. Model Specialization:
- ConvTran: Gold standard for anomalies
- ROCKET: Best 3PN detection
- LSTMFCN: Balanced 2PN performance (F1=0.75)

4. Critical Insights:
- 0PN paradox: Perfect BA but F1=0.0 (no positive samples)
- 2.1PN excellence: ConvTran (F1=0.86) vs ROCKET (F1=0.73)

5. Clinical Protocol:
- Automated approval:
  - ConvTran anomalous classifications
  - Any model non-viable predictions
- Required human oversight:
  - 0PN/deg cases (despite perfect BA)
  - LSTMFCN anomalous assessments
  - Borderline 2.1PN predictions

Note: F1 Score <0.4 indicates high uncertainty, >0.7 indicates clinical reliability
